Start Date
March 31, 2011
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
123I-MIP-1072
Single IV dose
CCR/NCI - Molecular Imaging Program, Bethesda
Lead Sponsor
National Cancer Institute (NCI)
NIH
Molecular Insight Pharmaceuticals, Inc.
INDUSTRY